Treating brain metastases: current approaches and future directions.

about

Treating brain metastases: current approaches and future directions.

Item

http://www.wikidata.org/entity/Q36106920

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Treating brain metastases: current approaches and future directions.

@ast

Treating brain metastases: current approaches and future directions.

@en

type

Item

label

Treating brain metastases: current approaches and future directions.

@ast

Treating brain metastases: current approaches and future directions.

@en

prefLabel

Treating brain metastases: current approaches and future directions.

@ast

Treating brain metastases: current approaches and future directions.

@en

P1476

Treating brain metastases: current approaches and future directions.

@en

P2093

David G Kirsch

http://www.w3.org/2001/XMLSchema#string

Jay S Loeffler

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

The role of chemotherapy in brain metastases.

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Response to topotecan of symptomatic brain metastases of small-cell lung cancer also after whole-brain irradiation. a multicentre phase II study.

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.

Prophylactic cranial irradiation revisited: cost-effectiveness and quality of life in small-cell lung cancer.

The role of topotecan in the treatment of brain metastases.

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

P304

1015-1022

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737175.4.6.1015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15853528

http://www.w3.org/2001/XMLSchema#string